Fundz

BioIVT completes acquisition of ZenBio Inc. to advance global research in drug discovery and cosmetics

PRIVATEAug 21, 2024

Acquiring Company

BioIVT

Acquired Company

ZenBio

DurhamManufacturingBiotechnology

Description

BioIVT, a global research partner and biospecimen solutions provider, has acquired ZenBio Inc., a distinguished industry leader in advanced cell products and services. This acquisition will allow BioIVT to offer an expanded portfolio of skin-based expertise, primary cell and exosome isolation, as well as blood products for pharmaceutical and cosmetics companies. The combined expertise will advance global research in drug discovery and cosmetics.

Quick answer

BioIVT is acquiring ZenBio, announced August 21, 2024.

How much did BioIVT pay for ZenBio?
The deal value was not disclosed.
What does BioIVT do?
BioIVT is a leading global provider of research models and value-added research services for drug discovery and development.
Where are BioIVT and ZenBio based?
ZenBio is based in Durham, North Carolina, United States.

Source: Fundz verified event record.

Other recent acquisitions in Manufacturing and Biotechnology

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at BioIVT, and when

When BioIVT changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day BioIVT raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BioIVT, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BioIVT. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BioIVT

About

BioIVT is a leading global provider of research models and value-added research services for drug discovery and development. We specialize in control and disease-state biospecimens including human and animal tissues, cell products, blood and other biofluids. Our unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples. And as the premier supplier of hepatic products, including hepatocytes and subcellular fractions, BioIVT enables scientists to better understand the pharmacokinetics and drug metabolism of newly discovered compounds and their effects on disease processes. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in elevating science. For more information, please visit www.bioivt.com or follow the company on Twitter @BioIVT.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BioIVT makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for BioIVT's next move

Learn about Strategic plan

Frequently asked

Who acquired ZenBio?

ZenBio was acquired by BioIVT. The deal was reported on August 21, 2024. BioIVT is a leading global provider of research models and value-added research services for drug discovery and development. BioIVT is privately held.

When did BioIVT acquire ZenBio?

BioIVT's acquisition of ZenBio was reported on August 21, 2024. BioIVT, a global research partner and biospecimen solutions provider, has acquired ZenBio Inc., a distinguished industry leader in advanced cell products and services. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does ZenBio do?

ZenBio Inc. is a highly regarded science-focused company specializing in biospecimens and related services with scientific expertise and flexibility to meet researchers' needs. It is privately held, operating in Manufacturing, and is based in Durham.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.